T-cell therapies for cancer: from outsider to pharmaceutical darling Less than a decade ago, work on T-cell therapies by a handful of researchers was snubbed by their peers but now the field has exploded, money has poured in and there is a race on to see who can bring the technology to patients the quickest.…
Time to recognise the importance of non-patient facing roles in pharmacy Pharmacists are needed and are just as important in roles that are not clinical or patient facing.…
How to tailor medication formulations for patients with dysphagia An overview of dysphagia and how to ensure patients are receiving the safest and most efficacious oral formulations.…
The future of the UK post-Brexit Two months on from the referendum vote to exit the EU, English Pharmacy Board member Sid Dajani puts forward his ideas on the potential impact on medicine and what the RPS should be doing to minimise the fallout.…
Lung disease patients still don’t use inhalers properly Data spanning 40 years show only 31% of patients with asthma or COPD use inhalers correctly, prompting calls for new approaches to education and drug delivery.…
New care models: the role of pharmacy in vanguard pilots Pharmacists are taking on roles in vanguard projects, working in both hospital and community settings as part of multidisciplinary teams that are developing new models of care.…
Deaths: Livia SchustekOn 30 June 2016, Livia Schustek MRPharmS, aged 73, of Cobham, Surrey. Mrs Schustek registered with the Society in 1972.…
Lord Peston’s influence in the development of pharmacy educationIn his tribute to Maurice Peston ( The Pharmaceutical Journal 2016;297:60), Mark Burdon was correct in concluding that his association with pharmacy started with his appointment as a member of the Nuffield Committee of Enquiry on Pharmacy. That committee was established not long aft…
Non-patient facing roles in hospital pharmacy are just as vital as patient facing ones Roles such as procurement are important in hospital pharmacy services and should not be brushed aside.…
Orlistat side effects were underreported, study shows Adverse effects that occurred during clinical trials of Roche’s obesity drug orlistat in the 1990s appear to have been substantially underreported in both published papers and summarised clinical study reports submitted to the European Medicines Agency for drug approval, an analysis has found.…
